Results: 43

Thermotolerance of Histoplasma capsulatum at 40 °C predominates among clinical isolates from different Latin American regions

Braz. j. infect. dis; 24 (1), 2020
ABSTRACT The yeast phase of 22 Histoplasma capsulatum clinical isolates from Mexico, Argentina, Colombia, and Guatemala and three reference strains, one from Panama and two from the United States of America (USA), were screened for thermosensitivity characteristics using different analyses. Growth curves...

Postpartum histoplasmosis in an HIV-negative woman: a case report and phylogenetic characterization by internal transcribed spacer region analysis

Abstract The present report describes the first case of postpartum disseminated histoplasmosis in a 24-year-old HIV-negative woman. On the tenth day after vaginal delivery, the patient presented with dyspnea, fever, hypotension, tachycardia, and painful hepatomegaly. Yeast-like Histoplasma capsulatum fea...

Histoplasmosis: epidemiología, diagnóstico y terapéutica

La histoplasmosis es una enfermedad granulomatosa, producida por hongos dimorfos del género Histoplasma. Se observa en casi todos los países del mundo. En América Latina, en Venezuela, Colombia, Brasil, Argentina, Ecuador, Perú, Paraguay y Uruguay, entre otros. Datos epidemiológicos recienteshanmost...

Uso de Anfotericina B: pacientes con linfoma no Hodgkin células B tipos burkitt por histoplasma capsulatum
Use of Amphotericin B: patients with non-Hodgkin lymphoma B cells burkitt type by histoplasma capsulatum

Rev. venez. oncol; 31 (1), 2019
El linfoma no Hodgkin comprende un grupo de enfermedades relacionadas entre sí. Cada variedad histológica de linfoma no Hodgkin se caracteriza por la transformación maligna de las células linfoides, con morfología, inmunofenotipo, genética y clínica diferente. Entre la etiología encontramos: viru...

Histoplasma panniculitis in a patient with systemic lupus erythematosus

An. bras. dermatol; 94 (1), 2019
Abstract: Histoplasmosis usually presents primarily as lung infection. Occasionally, mainly in immunocompromised hosts, it can spread and cause systemic manifestations. Skin lesions have been reported in 10 to 15 percent of cases of disseminated histoplasmosis, and panniculitis has been described as an u...

Caracterización de los pacientes con diagnóstico de Histoplasmosis en el Hospital Universitario de San Ignacio entre 2012 a 2016

Infectio; 23 (1), 2019
Introducción: La histoplasmosis diseminada es una forma de presentación común en pacientes inmunosuprimidos. La introducción de nuevos métodos diagnós ticos y la mejoría de la sobrevida de los pacientes con VIH pueden hacer cambiar las características clínicas de los pacientes con esta enfermeda...

Predictive factors for disseminated histoplasmosis in AIDS patients with fever admitted to a reference hospital in Brazil

Abstract INTRODUCTION: In many settings, the lack of sensitive biomarkers of disseminated histoplasmosis (DH) leads to a clinical reliance on older diagnostic methods and delayed treatment initiation. The early recognition of DH is critical for survival, especially in patients with human immunodeficien...

Histoplasma capsulatum: ¿un agente emergente para Chile?

Rev. chil. infectol; 35 (3), 2018
Resumen En los últimos 11 meses, nuestro laboratorio ha diagnosticado 9 casos de histoplasmosis de presentación clínica en el territorio nacional. Todos los pacientes asociados a los cuadros clínicos son inmigrantes. Por medio del presente trabajo deseamos difundir y alertar a los profesionales de lo...

Multiplex polymerase chain reaction as an improved method for screening Histoplasma capsulatum mating types

Mem. Inst. Oswaldo Cruz; 113 (10), 2018
Histoplasmosis is a systemic mycosis infection caused by Histoplasma capsulatum, a heterothallic ascomycete. The sexual reproduction of this fungus is regulated by the mating type (MAT1) locus that contains MAT1-1 and MAT1-2 idiomorphs, which were identified by uniplex polymerase chain reaction (PCR). Th...

Lesiones cutáneas como manifestación de una histoplasmosis diseminada en un hospital del Perú

Rev. chil. infectol; 34 (6), 2017
The dermatological manifestations of disseminated histoplasmosis present in about 17% of the cases, is a challenge for its diagnosis. We report the case of a patient from the northern coast of Peru, who presented diffuse dermal lesions, erythema-violaceous nodules, and ulcers histopathologically compatib...